YALELAAN 62, 3584 CM UTRECHT, P7
Acquisition Agreement with Genmab A/S for Common Shares at $97.00 Each
Merus N.V. Completes Acquisition of Common Shares from Genmab A/S
Merus N.V. Holds Extraordinary General Meeting for Shareholder Votes
To Acquire , Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
Material Contracts
Other Events
Shareholder votes
Q3
Q2
Q1
Amended Annual Report
FY 2024
Notice of Suspension of Duty to File Reports
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Tender Offer Statement by Issuer
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Merger Proxy Statement
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Amended Notification Filed by a National Security Exchange
Statement of Changes in Beneficial Ownership
Schedule 13D - Ownership Report
Initial Statement of Beneficial Ownership
Amended Schedule 14D-9 Solicitation/Recommendation Statement
Amended Tender Offer Statement by Third Party
S-8 POS